Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans
- 1 January 2001
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 61 (2), 173-181
- https://doi.org/10.1016/s0376-8716(00)00141-1